Lanean...
Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs
Canavan disease (CD) is a fatal leukodystrophy caused by mutation of the aspartoacylase (ASPA) gene, which leads to deficiency in ASPA activity, accumulation of the substrate N‐acetyl‐L‐aspartate (NAA), demyelination, and spongy degeneration of the brain. There is neither a cure nor a standard treat...
Gorde:
| Argitaratua izan da: | Adv Sci (Weinh) |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7709977/ https://ncbi.nlm.nih.gov/pubmed/33304759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.202002155 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|